Cargando…
The possibility of lapatinib treatment for breast cancer patients with central nervous system metastases. Case study and literature review
In patients with breast cancer with overexpression of the HER2 receptor, during treatment with trastuzumab, in 30% of cases brain metastases are observed. The use of lapatinib with capecitabine (L + C) seems to be an efficacious method of curing patients in whom the spread of cancer in this location...
Autores principales: | Rolski, Janusz, Karczmarek-Borowska, Bożenna, Śmietana, Anetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687474/ https://www.ncbi.nlm.nih.gov/pubmed/23788948 http://dx.doi.org/10.5114/wo.2012.32494 |
Ejemplares similares
-
Radioembolization treatment for liver metastases
por: Kiszkaą, Joanna, et al.
Publicado: (2017) -
A Rare Case of Breast Malignant Phyllodes Tumor With Metastases to the Kidney: Case Report
por: Karczmarek-Borowska, Bożenna, et al.
Publicado: (2015) -
Hepatotoxicity of molecular targeted therapy
por: Karczmarek-Borowska, Bożenna, et al.
Publicado: (2014) -
Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015) -
The incidence of breast cancer in population of young women from Podkarpackie province in 2002–2011
por: Radziszewska, Aneta U., et al.
Publicado: (2016)